SmartSkin Technologies is proud to announce Claus Abildgren as the newest addition to our pharmaceutical team.

Claus brings over two decades of experience in manufacturing technology, digital transformation, and strategic leadership, making him an exceptional addition to our mission of enabling zero-defect manufacturing in the pharma manufacturing industry.

Claus’s career highlights include his tenure as Chief Revenue Officer at Aizon, where he led the sales and marketing efforts to drive value from modern AI technologies within GMP regulated industries , enabling predictive optimization and enhanced drug production quality. His leadership has driven significant growth in multiple organizations, securing over $35 million in funding for startups focused on Industry 4.0 and SaaS solutions. Earlier in his career, his work with Invensys centered around close integration of advanced manufacturing execution systems (MES) and enterprise manufacturing intelligence (EMI) solutions, delivering tangible benefits such as improved operational efficiency and reduced waste.

At SmartSkin, Claus will focus on optimizing fill/finish operations for some of the world’s largest pharmaceutical manufacturers. His vision and deep understanding of advanced manufacturing technologies will be instrumental in helping our clients meet growing regulatory demands, enhance operational efficiency, and protect product integrity.

We are excited about the expertise and innovative perspective Claus brings to our team. His contributions will strengthen SmartSkin’s ability to drive transformative solutions for our clients and the industry. Please join us in welcoming Claus to the SmartSkin family.